©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
G and G Stimulate Rho-dependent Stress Fiber Formation and Focal Adhesion Assembly (*)

(Received for publication, July 12, 1995)

Anne Mette Buhl (1) (2)(§) Nancy Lassignal Johnson (2) N. Dhanasekaran (3) Gary L. Johnson (2) (4)(¶)

From the  (1)Division of Biostructural Chemistry, Department of Chemistry, Aarhus University, DK-8000 Aarhus C, Denmark, the (2)Division of Basic Sciences, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206, (3)Fels Institute for Cancer Research and Molecular Biology and the Department of Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, and the (4)Department of Pharmacology, University of Colorado Medical School, Denver, Colorado 80206

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Rho, a member of the Ras superfamily of GTP-binding proteins, regulates actin polymerization resulting in the formation of stress fibers and the assembly of focal adhesions. In Swiss 3T3 cells, heterotrimeric G protein-coupled receptors for lysophosphatidic acid and gastrin releasing peptide stimulate Rho-dependent stress fiber and focal adhesion formation. The specific heterotrimeric G protein subunits mediating Rho-dependent stress fiber and focal adhesion formation have not been defined previously. We have expressed GTPase-deficient, constitutively activated G protein alpha subunits and mixtures of beta and subunits in Swiss 3T3 cells. Measurement of actin polymerization and focal adhesion formation indicated that GTPase-deficient alpha and alpha, but not the activated forms of alpha or alpha(q) stimulated stress fiber and focal adhesion assembly. Combinations of beta and subunits were unable to stimulate stress fiber or focal adhesion formation. Galpha- and alpha-mediated stress fiber and focal adhesion assembly was inhibited by botulinum C3 exoenzyme, which ADP-ribosylates and inactivates Rho, indicating that alpha and alpha, but not other G protein alpha subunits or beta complexes, regulate Rho-dependent responses. The results define the integration of G and G with the regulation of the actin cytoskeleton.


INTRODUCTION

The heterotrimeric G protein-coupled receptors for lysophosphatidic acid (LPA), (^1)gastrin releasing peptide (GRP or bombesin), and thrombin are capable of stimulating the growth of specific cell types(1, 2, 3) . LPA and thrombin receptors have been shown to stimulate Ras GTP loading which is required for the mitogenic response to these ligands(4, 5) . Ras GTP loading in response to LPA and thrombin activation of their receptors requires the heterotrimeric G proteins G(i) or G(q)(5, 6, 7) . GRP receptors are mitogenic in Swiss 3T3 cells, lung epithelia, and small cell lung carcinoma cells(2, 9) ; GRP receptors activate G(q) and phospholipase C activity but stimulate little or no GTP loading of Ras(10) . In addition to the stimulation of mitogenic responses, the LPA, GRP, and thrombin receptors regulate the polymerization of actin to produce stress fibers and the assembly of focal adhesions(11) . The stimulation of stress fiber and focal adhesion assembly has been demonstrated to be regulated by Rho(12, 13) .

The polymerization of actin and the actin cytoskeleton is important for cell shape and regulatory responses including chemotaxis and mitogenesis. In quiescent Swiss 3T3 cells, the formation of stress fibers generally parallels the assembly of focal adhesions. Focal adhesions are oligomeric protein complexes that include p125, paxillin, talin, alpha-actinin, vinculin, and other proteins(14, 15) . Focal adhesions link actin stress fibers to integrins at the inner surface of the plasma membrane. How Rho regulates the assembly of focal adhesions and the formation of stress fibers is currently ill-defined. Similarly, the heterotrimeric G proteins that couple LPA, GRP, and thrombin receptors to Rho activation have not been defined. Pertussis toxin does not inhibit receptor-stimulated actin polymerization or focal adhesion assembly, indicating that neither G(o) nor G(i) mediates these responses(16) . Similarly, calcium ionophores and phorbol esters do not stimulate Rho-dependent responses suggesting that G(q) activation of phospholipase C is not involved(16) .

To define which heterotrimeric G protein subunits were involved in stimulating Rho-dependent actin polymerization to produce stress fibers and focal adhesion assembly, we microinjected expression plasmids encoding GTPase-deficient mutant heterotrimeric G protein alpha subunits into the nuclei of serum-starved, quiescent Swiss 3T3 cells. For each G protein alpha subunit, the conserved glutamine (Q) adjacent to the G3 sequence of the GDP/GTP binding domain of the polypeptide was mutated to a leucine (L). The Gln Leu mutation functionally inhibits the GTPase activity of the polypeptide resulting in a constitutively activated G protein alpha subunit(17, 18) . This mutation corresponds to residue 229 in alpha and 226 in alpha. In addition, different combinations of beta and subunits were microinjected. Each expression plasmid used in the experiments was characterized previously for functional expression (19, 20, 21) . Following microinjection, cells were stained with rhodamine-phalloidin to identify stress fibers or anti-vinculin antibody for the identification of focal adhesions. Microinjected cells were marked by coinjection of G protein subunit expression plasmids with a plasmid encoding beta-galactosidase.


EXPERIMENTAL PROCEDURES

For microinjection, Swiss 3T3 cells were plated at approximately 10% confluency on acid-washed glass coverslips in Dulbecco's modified Eagle's medium (DMEM) with 5% bovine calf serum (BCS) and 5% newborn calf serum (NCS). The next day, cells were rinsed three times and placed in 0.1% BCS/DMEM. Twenty-four h later, cells were rinsed three times in DMEM in the absence of serum and incubated for an additional 18 h before microinjection. Injections were performed with an Eppendorf automated microinjection system with needles pulled from glass capillaries on a vertical pipette puller (Kopf, Tujunga, CA). The cDNAs used for expression were inserted in either pCMV5 or pCDNA3 and have been characterized for functional expression. All plasmids were prepared by cesium chloride gradient centrifugation and used at 100 ng/µl for microinjection into the nuclei of Swiss 3T3 cells. The botulinum C3 exoenzyme pGEX2T vector was a gift from Drs. S. Dillon and L. Feig, Tufts Medical School, Boston, MA. The C3 fusion protein was induced, cleaved with thrombin, and purified as described (22) . The pCMV5RhoAQL plasmid was a gift from Dr. Sim Winitz, Scripps Research Foundation, La Jolla, CA. Two- to three-h postnuclear injection cells were fixed in 3% paraformaldehyde for 10 min. Cells were rinsed in phosphate-buffered saline and permeabilized using 0.2% Triton X-100 for 5 min. The fixed and permeabilized cells were then incubated with DMEM/5% BCS/5% NCS for 15 min. beta-Galactosidase was stained using a rabbit anti-beta-galactosidase antibody (Cappel) and a secondary FITC-conjugated donkey anti-rabbit antibody (Pierce). Rhodamine-phalloidin (Molecular Probes) was used to label F-actin. Focal adhesions were stained using a mouse monoclonal anti-vinculin antibody (Sigma) and a secondary FITC-conjugated sheep anti-mouse (Cappel) antibody. When cells were stained for vinculin, a rhodamine-conjugated goat anti-rabbit antibody (Cappel) was used for detection of beta-galactosidase. Coverslips were mounted on slides and examined with a Nikon Diaphot TMD microscope with eipfluorescence. Images of cells were captured using the IPLAB Spectrum digital image analysis program (Signal Analytics Co., Vienna, VA). All experiments were done at least 3 times with similar results.


RESULTS AND DISCUSSION

Fig. 1shows that constitutively activated RhoA having glutamine 63 mutated to leucine (RhoQL), which corresponds to the Q61L mutation in p21, induces stress fiber formation in Swiss 3T3 cells. Strikingly, the Gln Leu mutant alpha subunits for G (alphaQL) and G (alphaQL), when expressed in Swiss 3T3 cells, mimicked activated RhoQL in stimulating the formation of stress fibers. The activated forms of alpha and alpha were capable of stimulating stress fiber formation in quiescent Swiss 3T3 cells. Activated, GTPase-deficient forms of alpha (alphaQL) or alpha(q) (alpha(q)QL) were unable to induce stress fiber formation (Fig. 2). Expression of alpha(q)QL appears to disorder stress fibers and cause a loss of cortical actin along the cytoplasmic surface of the plasma membrane. Expression of beta(1)(2) or beta(2)(2) also did not induce stress fiber formation in Swiss 3T3 cells. Similarly, neither beta(1)(3) nor beta(2)(3) had any effect on the actin network when injected into Swiss 3T3 cells (not shown). In addition, treatment of quiescent Swiss 3T3 cells with forskolin to stimulate cAMP synthesis, phorbol esters to activate protein kinase C, and ionomycin to elevate intracellular calcium does not induce stress fiber formation(16) . Our results demonstrate that alpha and alpha, but not other G protein alpha subunits or second messengers, stimulate stress fiber formation.


Figure 1: Activated, GTPase-deficient mutants of RhoA, alpha, and alpha stimulate stress fiber formation. Quiescent Swiss 3T3 cells were nuclear microinjected with pCMVbetagal in the presence of either pCMVRhoQL, pCDNA3alphaQL, or pCDNA3alphaQL. Microinjected cells were detected by indirect immunofluorescent staining of beta-galactosidase. Immunostaining of cells injected with alphaQL and alphaQL with specific C-terminal peptide antisera showed expression of both constructs in injected cells (not shown). Stress fibers were monitored using rhodamine-phalloidin. Uninjected cells in the field that are negative for beta-galactosidase staining show few stress fibers, whereas cells expressing activated Rho, alpha, or alpha show similar increased levels of stress fibers.




Figure 2: Stress fiber formation is specific for Galpha and Galpha. Swiss 3T3 cells were nuclear microinjected with pCMVbetagal in the presence of expression plasmids encoding inserts for alphaQL, alphaQL, alpha(q)QL, beta(1) and (2), or beta(2) and (2) cDNAs. Each expression plasmid was characterized to demonstrate functional expression of the specific G protein alpha subunit in transfection experiments (not shown). Microinjected cells were detected by staining for beta-galactosidase.



Expression of RhoQL in quiescent Swiss 3T3 cells also stimulates focal adhesion assembly (Fig. 3). Microinjection and expression of alphaQL and alphaQL mimicked RhoQL in stimulating focal adhesion assembly, as measured by the localization of vinculin, at the leading edge of cells. Thus, activated forms of alpha and alpha regulate the polymerization of actin and the assembly of focal adhesions similar to that observed with RhoQL.


Figure 3: Activated alpha and alpha stimulate focal adhesion assembly. Swiss 3T3 cells were nuclear microinjected with expression plasmids encoding RhoQL, alphaQL, or alphaQL in the presence of pCMVbetagal. Cells were then fixed and stained with an anti-vinculin antibody to detect focal adhesions. Injected cells were detected by staining for beta-galactosidase.



To demonstrate that the action of alphaQL and alphaQL were Rho-dependent, the cells were injected with recombinant, purified botulinum C3 exoenzyme. Botulinum C3 exoenzyme has been shown to catalyze the ADP-ribosylation of Asn-41 in the Rho polypeptide resulting in the inhibition of Rho activity(23, 24) . Fig. 4shows that microinjection of botulinum C3 exoenzyme inhibits LPA-stimulated stress fiber formation. To demonstrate that the botulinum C3 exoenzyme was selectively inhibiting Rho-dependent effects on the actin cytoskeleton, cells were also stimulated with platelet-derived growth factor (PDGF). PDGF has been shown to stimulate Rac1-dependent actin polymerization that is associated with membrane ruffling(25, 26) ; PDGF-stimulated membrane ruffling is unaffected by microinjection of botulinum C3 exoenzyme (Fig. 4, middle panel). Microinjection of botulinum C3 exoenzyme inhibited both alphaQL- and alphaQL-stimulated stress fiber formation (Fig. 5) similar to the inhibition of LPA-stimulated actin polymerization (Fig. 4). As predicted, botulinum C3 exoenzyme also inhibited LPA- and alphaQL-stimulated focal adhesion formation (Fig. 6). In other experiments, the botulinum C3 exoenzyme also inhibited alphaQL-stimulated focal adhesion assembly (not shown).


Figure 4: Botulinum C3 exoenzyme inhibition of Rho-dependent actin polymerization. Cells were microinjected with pCMVbetagal and purified botulinum C3 exoenzyme (100 ng/µl). After 2-3 h, cells were stimulated for 10 min with either LPA (200 ng/ml), PDGF (3 ng/ml), or buffer only (Control). Cells were fixed and microinjected cells detected by staining for beta-galactosidase. LPA-stimulated stress fiber formation is observed in uninjected cells, whereas stress fiber formation was inhibited by botulinum C3 exoenzyme in the injected cells. PDGF-stimulated membrane ruffling was unaffected in the botulinum C3 exoenzyme injected cells.




Figure 5: Botulinum C3 exoenzyme inhibits activated alpha- and alpha-stimulated stress fiber formation. Swiss 3T3 cells were microinjected with pCMVbetagal and alphaQL- or alphaQL-encoded expression plasmids in the presence or absence of botulinum C3 exoenzyme (100 ng/µl). Microinjected cells were detected by staining for beta-galactosidase.




Figure 6: Botulinum C3 exoenzyme inhibits LPA- and alphaQL-stimulated focal adhesion assembly. Swiss 3T3 cells were microinjected with pCMVbetagal in the presence or absence of pCDNA3alphaQL and botulinum C3 exoenzyme (100 ng/µl). The indicated panel of cells was stimulated for 10 min with LPA (200 ng/ml). Injected cells were detected by staining for beta-galactosidase and focal adhesions monitored by staining for vinculin. Uninjected cells in the upper panel responded to LPA with the assembly of focal adhesions while focal adhesions are absent in the botulinum C3 exoenzyme injected cell. Botulinum C3 exoenzyme also inhibited focal adhesion assembly in response to alphaQL. Similar results were obtained for alphaQL (not shown).



These studies clearly demonstrate that alpha and alpha regulate Rho-dependent actin polymerization resulting in stress fiber formation and the assembly of focal adhesions. G and G have been shown previously to interact with the thrombin receptor(27) , and G was shown to couple to the bradykinin receptor(28) , two receptors that stimulate actin polymerization responses in Swiss 3T3 cells. Both Galpha and alpha subunits are expressed in Swiss 3T3 cells as determined by immunoblotting (not shown). Our results suggest that alpha and alpha behave similarly in their ability to stimulate Rho-dependent stress fiber formation and focal adhesion assembly. This finding indicates that alpha and alpha probably interact with a common effector regulating Rho activation. Whether this effector is a dbl- or lbc-like Rho exchange factor (29, 30) or a Rho GDI or GDS protein characterized by Takai and co-workers (31, 32) is presently unclear. Nonetheless, the results clearly demonstrate that alpha and alpha integrate heterotrimeric G protein-coupled receptors with the regulation of Rho. Thus, it is becoming increasingly apparent that specific G protein subunits differentially regulate the activation of low molecular weight GTP-binding proteins of the Ras and Rho families(33, 34) . The Ras and Rho superfamily of low molecular weight GTP-binding proteins are key regulators of major phenotypic responses of cells including growth, apoptosis, chemotaxis, and cell shape. The ability of seven transmembrane receptors to couple to specific G proteins determines the ability of receptor agonists to regulate the responses controlled by different low molecular weight GTP-binding proteins. G- and G-coupled receptors will function to regulate specific actin cytoskeleton responses. Activated Rho exchange factors have been shown to alter the growth and to transform NIH3T3 cells(29) . It is probable that the ability of alpha and alpha to alter the growth and to transform specific cell types is related in part to the regulation of Rho and the downstream functions controlled by Rho. It will be interesting to determine if regulatory events such as activation of Na/H antiporter activity by alpha and alpha(35, 36) involves Rho-dependent pathways as well.


FOOTNOTES

*
This work was supported in part by National Institutes of Health Grants DK 37871, GM 30324, and CA 58157. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Recipient of a grant from the Danish Natural Science Research Council.

To whom correspondence should be addressed: Division of Basic Sciences, National Jewish Center for Immunology and Respiratory Medicine, 1400 Jackson St., Denver, CO 80206. Tel.: 303-398-1504; Fax: 303-398-1225.

(^1)
The abbreviations used are: LPA, lysophosphatidic acid; GRP, gastrin releasing peptide; DMEM, Dulbecco's modified Eagle's medium; BCS, bovine calf serum; NCS, newborn calf serum; PDGF, platelet-derived growth factor.


REFERENCES

  1. Van Corven, E. J., Groenik, A., Jalink, K., Eicholz, T., and Moolenaar, W. H. (1989) Cell 59,45-54 [Medline] [Order article via Infotrieve]
  2. Rozengurt, E., and Sinnett-Smith, J. (1983) Proc. Natl. Acad. Sci. U. S. A. 80,2936-2940 [Abstract]
  3. Chambard, J. C., Paris, S., L'Allemain, G., and Pouyssegur, J. (1987) Nature 326,800-803 [CrossRef][Medline] [Order article via Infotrieve]
  4. Van Corven, E. J., Hordijk, P. L., Medema, R. H., Bos, J. L., and Moolenaar, W. H. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,1257-1261 [Abstract]
  5. Hordijk, P. L., Verlaan, I., Van Corven, E. J., and Moolenaar, W. H. (1994) J. Biol. Chem. 269,645-651 [Abstract/Free Full Text]
  6. Hung, D. T., Wong, Y. H., Vu, T.-K., and Coughlin, S. R. (1992) J. Biol. Chem. 267,20831-20834 [Abstract/Free Full Text]
  7. Baffy, G., Yang, L., Raj, S., Manning, D. R., and Williamson, J. R. (1994) J. Biol. Chem. 269,8483-8487 [Abstract/Free Full Text]
  8. Deleted in proof
  9. Cuttitta F., Carney, D. N., Mulshine, J., Moody, T. W., Fedorko, J., Fischler, A., and Minna, J. D. (1985) Nature 316,823-826 [Medline] [Order article via Infotrieve]
  10. Mitchell, F. M., Heasley, L. E., Qian, N.-X., Zamarripa, J., and Johnson, G. L. (1995) J. Biol. Chem. 270,8623-8628 [Abstract/Free Full Text]
  11. Ridley, A. J., and Hall, A. (1992) Cell 70,389-399 [Medline] [Order article via Infotrieve]
  12. Chardin, P., Boquet, P., Modaule, P., Popoff, M. R., Rubin, E. J., and Gill, D. M. (1989) EMBO J. 8,1087-1092 [Abstract]
  13. Paterson, H. F., Self, A. J., Garrett, M. D., Just, I., Aktories, K., and Hall, A. (1990) J. Cell. Biol. 111,1001-1009 [Abstract]
  14. Zachary, I., and Rozengurt, E. (1992) Cell 71,891-894 [Medline] [Order article via Infotrieve]
  15. Clark, E. A., and Brugge, J. S. (1995) Science 268,233-238 [Medline] [Order article via Infotrieve]
  16. Ridley, A. J., and Hall, A. (1994) EMBO J. 13,2600-2610 [Abstract]
  17. Osawa, S., Dhanasekaran, N., Woon, C. W., and Johnson, G. L. (1990) Cell 63,697-706 [Medline] [Order article via Infotrieve]
  18. Masters, S. B., Tyler Miller, R., Chi, M.-H., Chang, F.-H., Beiderman, B., Lopez, N. G., and Bourne, H. R. (1989) J. Biol. Chem. 264,15467-15474 [Abstract/Free Full Text]
  19. Lowndes, J. M., Gupta, S. K., and Johnson, G. L. (1991) J. Biol. Chem. 266,14193-14197 [Abstract/Free Full Text]
  20. Qian, N.-X., Winitz, S., and Johnson, G. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,4077-4081 [Abstract]
  21. Vara Prasad, M. V. V. S., Dermott, J. M., Heasley, L. E., Johnson, G. L., and Dhanasekaran, N. (1995) J. Biol. Chem. 270,18655-18659 [Abstract/Free Full Text]
  22. Dillon, S. T., and Feig, L. A. (1995) Methods Enzymol. 256,174-184 [Medline] [Order article via Infotrieve]
  23. Aktories, K., Braun, U., Rosener, S., Just, I., and Hall, A. (1989) Biochem. Biophys. Res. Commun. 158,209-213 [Medline] [Order article via Infotrieve]
  24. Sekine, A., Fujiwara, M., and Naramiya, S. (1989) J. Biol. Chem. 264,8602-8605 [Abstract/Free Full Text]
  25. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., and Hall, A. (1992) Cell 70,401-410 [Medline] [Order article via Infotrieve]
  26. Rankin, S., and Rozengurt, E. (1994) J. Biol. Chem. 269,704-710 [Abstract/Free Full Text]
  27. Offermanns, S., Langwitz, K. D., Spicher, K., and Schultz, G. (1994) Proc. Natl. Acad. Sci. U. S. A. 91,504-508 [Abstract]
  28. Wilk-Blaszczak, M. A., Singer, W. D., Gatowski, S., Sternweiss, P. C., and Belardetti, F. (1994) Neuron 13,1215-1224 [Medline] [Order article via Infotrieve]
  29. Khosravi-Far, R., Chrzanowska-Wodnicka, M., Solski, P. A., Eva, A., Burridge, K., and Der, C. (1994) J. Mol. Cell. Biol. 14,6848-6857
  30. Zheng, Y., Olson, M. F., Hall, A., Cerione, R. A., and Tosksoz, D. (1995) J. Biol. Chem. 270,9031-9034 [Abstract/Free Full Text]
  31. Fukumoto, Y., Kaibuchi, K., Hari, Y., Fujioka, H., Araki, S., Ueda, T., Kikuchi, A., and Takai, Y. (1990) Oncogene 5,1321-1338 [Medline] [Order article via Infotrieve]
  32. Kaibuchi, K., Mizuno, T., Fujioka, H., Yamamoto, T., Kishi, K., Fukumoto, Y., Hori, Y., and Takai, Y. (1991) Mol. Cell. Biol. 11,2873-2880 [Medline] [Order article via Infotrieve]
  33. Boguski, M. S., and McCormick, F. (1993) Nature 366,643-654 [CrossRef][Medline] [Order article via Infotrieve]
  34. Burgering, B. H. T., and Bos, J. L. (1995) Trends Biochem. Sci. 20,18-22 [CrossRef][Medline] [Order article via Infotrieve]
  35. Dhanasekaran, N., Vara Prasad, M. V. V. S., Wadsworth, S. J., Dermott, J. M., and van Rossum, G. (1994) J. Biol. Chem. 269,11802-11806 [Abstract/Free Full Text]
  36. Voyno-Yasenetskaya, T., Conklin, B. R., Gilbert, R. L., Hooley, R., Bourne, H. R., and Barber, D. L. (1994) J. Biol. Chem. 269,4721-4724 [Abstract/Free Full Text]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.